Publikationen von Eva-Maria Mandelkow

Kumar, S.; Tepper, K.; Kaniyappan, S.; Biernat, J.; Wegmann, S.; Mandelkow, E.-M.; Müller, D. J.; Mandelkow, E.: Stages and conformations of the Tau repeat domain during aggregation and its effect on neuronal toxicity. Journal of Biological Chemistry 289 (29), S. 20318 - 20332 (2014)

Matenia, D.; Mandelkow, E.-M.: Emerging modes of PINK1 signaling: Another task for MARK2. Frontiers in Molecular Neuroscience 7 (May), 37 (2014)

Hochgräfe, K.; Mandelkow, E.-M.: Making the brain glow: In vivo bioluminescence imaging to study neurodegeneration. Molecular Neurobiology 47 (3), S. 868 - 882 (2013)

Hochgräfe, K.; Sydow, A.; Mandelkow, E.-M.: Regulatable transgenic mouse models of Alzheimer disease: Onset, reversibility and spreading of Tau pathology. FEBS Journal 280 (18), S. 4371 - 4381 (2013)

Messing, L.; Decker, J. M.; Joseph, M.; Mandelkow, E.; Mandelkow, E.-M.: Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors. Neurobiology of Aging 34 (5), S. 1343 - 1354 (2013)

Fatouros, C.; Pir, G. J.; Biernat, J.; Koushika, S. P.; Mandelkow, E.; Mandelkow, E.-M.; Schmidt, E.; Baumeister, R.: Inhibition of Tau aggregation in a novel caenorhabditis elegans model of tauopathy mitigates proteotoxicity. Human Molecular Genetics 21 (6), S. 3587 - 3603 (2012)

Van der Jeugd, A.; Hochgräfe, K.; Ahmed, T.; Decker, J. M.; Sydow, A.; Hofmann, A.; Wu, D.; Messing, L.; Balschun, D.; D'Hooge, R. et al.; Mandelkow, E.-M.: Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau. Acta Neuropathologica 123 (6), S. 787 - 805 (2012)